Legendary Investor Stanley Druckenmiller Made Huge AI And Chipmaker Bets In Q2 - Here's What He Knows That You Don't - Broadcom ( NASDAQ:AVGO ) , Amazon.com ( NASDAQ:AMZN )
Legendary macro investor Stanley Druckenmiller made significant shifts in his portfolio in the second quarter, establishing major new positions in artificial intelligence and semiconductor leaders, rotating into large-cap banks, and placing a broadly bullish bet on the U.S. stock market, ...
Nvidia To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Celanese ( NYSE:CE ) , Carlyle Group ( NASDAQ:CG )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Guggenheim cut Eli Lilly and Company LLY price target from $942 to $875.
Why Is Insmed Stock Trading Higher Today - Insmed ( NASDAQ:INSM )
Brinsupri cuts annual NCFB exacerbations by up to 21% in Phase 3 trial. First FDA-approved treatment for 500,000 U.S. NCFB patients. This simple system has nailed 1,000+ post-earnings winners. Get in before Q3 trades take off → The U.S.
Don't Overlook Insmed ( INSM ) International Revenue Trends While Assessing the Stock
Explore Insmed's (INSM) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
$100 Invested In Insmed 10 Years Ago Would Be Worth This Much Today - Insmed ( NASDAQ:INSM )
Insmed INSM has outperformed the market over the past 10 years by 3.51% on an annualized basis producing an average annual return of 15.22%. Currently, Insmed has a market capitalization of $20.78 billion.
Insmed ( INSM ) Reports Q2 Loss, Beats Revenue Estimates
Insmed (INSM) delivered earnings and revenue surprises of -30.77% and +3.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Fortrea Holdings Inc. ( FTRE ) Beats Q2 Earnings and Revenue Estimates
Fortrea Holdings Inc. (FTRE) delivered earnings and revenue surprises of +216.67% and +12.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Insmed ( INSM ) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Beyond analysts' top-and-bottom-line estimates for Insmed (INSM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
The 5 Most Volatile Stocks This Week And How To Trade Them - Centene ( NYSE:CNC ) , Joby Aviation ( NYSE:JOBY )
After focusing on earnings for the bulk of last week, we're going to shift gears a bit today. This week, the spotlight is on implied volatility ( IV ) and, more importantly, five stocks poised to explode in the next week. We've discussed IV quite often and how, in many cases, it's easier to ...
Will Insmed ( INSM ) Report Negative Earnings Next Week? What You Should Know
Insmed (INSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should iShares Russell 2000 ETF ( IWM ) Be on Your Investing Radar?
Style Box ETF report for ...
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today - Insmed ( NASDAQ:INSM )
Insmed INSM has outperformed the market over the past 10 years by 2.94% on an annualized basis producing an average annual return of 14.32%. Currently, Insmed has a market capitalization of $18.67 billion.
Cramer Says Tesla Dominates While Ouster Is 'Too Speculative' - First Majestic Silver ( NYSE:AG ) , Insmed ( NASDAQ:INSM )
"I'm going to say no, too speculative," Cramer on Ouster. Jim Cramer says Tempus AI is another company that's just losing money "hand over fist." Get daily-updated rankings across momentum, growth, value, trends, and quality to spot the strongest stocks in any market.
Is SPDR S&P Biotech ETF ( XBI ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Here's How Much $100 Invested In Insmed 10 Years Ago Would Be Worth Today - Insmed ( NASDAQ:INSM )
Insmed INSM has outperformed the market over the past 10 years by 3.38% on an annualized basis producing an average annual return of 14.93%. Currently, Insmed has a market capitalization of $18.66 billion.
What Does the Market Think About Insmed? - Insmed ( NASDAQ:INSM )
Insmed's INSM short percent of float has risen 5.99% since its last report. The company recently reported that it has 17.46 million shares sold short, which is 10.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.27 days to cover their ...
Last week's top gainer large cap stocks - Halliburton ( NYSE:HAL ) , Oracle ( NYSE:ORCL ) , AST SpaceMobile ( NASDAQ:ASTS )
Insmed surged 34.1% after its Phase 2b study on treprostinil powder met all endpoints, prompting analyst price hikes. Oracle rose 23.7% on strong Q4 earnings and upbeat guidance, with multiple analysts raising their price targets.
United Therapeutics ( UTHR ) Soars 3.5%: Is Further Upside Left in the Stock?
United Therapeutics (UTHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
$100 Invested In Insmed 10 Years Ago Would Be Worth This Much Today - Insmed ( NASDAQ:INSM )
Insmed INSM has outperformed the market over the past 10 years by 4.43% on an annualized basis producing an average annual return of 15.51%. Currently, Insmed has a market capitalization of $17.70 billion.
Insmed's Pulmonary Hypertension Drug Data Exceeded Even Bullish Outlook, Analysts Boost Price Forecast - Insmed ( NASDAQ:INSM )
TPIP data "exceeded even our bullish outlook," says BofA, citing strong efficacy and promising safety profile. BofA raises Insmed price target to $109, citing upcoming catalysts including brensocatib's FDA decision by Aug. 12.
Insmed Stock Jumps 29% on Encouraging PAH Study Results
INSM eyes the next steps as TPIP hits all endpoints in the PAH study, setting the stage for late-stage trials and broader potential in lung disease.
Datadog To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday - Datadog ( NASDAQ:DDOG ) , Academy Sports ( NASDAQ:ASO )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham raised Lumentum Holdings Inc. LITE price target from $100 to $105.
Should iShares Russell 2000 Growth ETF ( IWO ) Be on Your Investing Radar?
Style Box ETF report for ...
3 Stocks With The 'Insider Advantage' - EVI Industries ( AMEX:EVI ) , Hamilton Beach Brands ( NYSE:HBB )
There's a well-worn line in value investing circles that says, "I want to invest with people who eat their own cooking." In other words, you want the people running the company to have a meaningful chunk of their net worth tied up in the business.
Dow Gains 50 Points; US Small Business Optimism Index Rises In May - Casey's General Stores ( NASDAQ:CASY ) , Calavo Growers ( NASDAQ:CVGW )
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 50 points n Tuesday. The Dow traded up 0.13% to 42,817.81 while the NASDAQ gained 0.22% to 19,634.48. The S&P 500 also rose, gaining, 0.29% to 6,023.46. Energy shares jumped by 1.9% on Tuesday.
Should Vanguard Russell 2000 ETF ( VTWO ) Be on Your Investing Radar?
Style Box ETF report for ...
Should Vanguard Russell 2000 Growth ETF ( VTWG ) Be on Your Investing Radar?
Style Box ETF report for ...
Should Global X Russell 2000 ETF ( RSSL ) Be on Your Investing Radar?
Style Box ETF report for ...
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Insmed ( NASDAQ:INSM )
Insmed INSM has outperformed the market over the past 5 years by 6.26% on an annualized basis producing an average annual return of 20.05%. Currently, Insmed has a market capitalization of $12.09 billion.
How Do Investors Really Feel About Insmed? - Insmed ( NASDAQ:INSM )
Insmed's INSM short percent of float has risen 4.37% since its last report. The company recently reported that it has 15.78 million shares sold short, which is 8.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.09 days to cover their ...
Is the Vanguard Russell 2000 Index Fund ETF a Buy Now?
The Russell 2000 is supposed to outperform in bull markets, but that hasn't been the case recently. Since the start of 2023, the Vanguard Russell 2000 Index Fund ( NASDAQ: VTWO ) -- an exchange-traded fund ( ETF ) -- is up just 19% compared to a 55% gain for the S&P 500.
Should iShares Russell 2000 ETF ( IWM ) Be on Your Investing Radar?
Style Box ETF report for ...
Unlocking Insmed ( INSM ) International Revenues: Trends, Surprises, and Prospects
Examine the evolution of Insmed's (INSM) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Evergy ( NASDAQ:EVRG ) , Black Hills ( NYSE:BKH )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Jefferies analyst Kelly Shi initiated coverage on Insmed Incorporated INSM with a Buy rating ...
Insmed's Q1 Loss Wider Than Expected, Sales Match Estimates
INSM posts wider-than-expected loss in the first quarter. It reiterates the 2025 sales outlook for Arikayce in the range of $405-$425 million.
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Insmed ( NASDAQ:INSM )
Insmed INSM has outperformed the market over the past 5 years by 6.96% on an annualized basis producing an average annual return of 21.46%. Currently, Insmed has a market capitalization of $11.88 billion.
Insmed ( INSM ) Reports Q1 Loss, Tops Revenue Estimates
Insmed (INSM) delivered earnings and revenue surprises of -4.41% and 0.18%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Is SPDR S&P Biotech ETF ( XBI ) a Strong ETF Right Now?
Smart Beta ETF report for ...
This Market Is The Buying Opportunity Of A Lifetime - Air Products & Chemicals ( NYSE:APD ) , British American Tobacco ( NYSE:BTI )
As May opens for business, shell-shocked stock market investors are waving goodbye to April with both hands. While the major stock indexes have bounced back moderately over the last week, stocks fell 11% at one point and declined 20% since mid-February, primarily due to tariff troubles affecting ...
Is Insmed Gaining or Losing Market Support? - Insmed ( NASDAQ:INSM )
Insmed's INSM short percent of float has risen 4.19% since its last report. The company recently reported that it has 15.12 million shares sold short, which is 8.46% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.44 days to cover their ...
Earnings Preview: Insmed ( INSM ) Q1 Earnings Expected to Decline
Insmed (INSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today - Insmed ( NASDAQ:INSM )
Insmed INSM has outperformed the market over the past 10 years by 3.02% on an annualized basis producing an average annual return of 13.16%. Currently, Insmed has a market capitalization of $12.29 billion.
Should iShares Morningstar Small-Cap ETF ( ISCB ) Be on Your Investing Radar?
Style Box ETF report for ...
Here's How Much You Would Have Made Owning Insmed Stock In The Last 5 Years - Insmed ( NASDAQ:INSM )
Insmed INSM has outperformed the market over the past 5 years by 14.56% on an annualized basis producing an average annual return of 28.37%. Currently, Insmed has a market capitalization of $12.86 billion.
Should iShares Russell 2000 Growth ETF ( IWO ) Be on Your Investing Radar?
Style Box ETF report for ...
Should iShares Morningstar Small-Cap Growth ETF ( ISCG ) Be on Your Investing Radar?
Style Box ETF report for ...
Should Vanguard Russell 2000 Growth ETF ( VTWG ) Be on Your Investing Radar?
Style Box ETF report for ...
Should Vanguard Russell 2000 ETF ( VTWO ) Be on Your Investing Radar?
Style Box ETF report for ...
Should Global X Russell 2000 ETF ( RSSL ) Be on Your Investing Radar?
Style Box ETF report for ...
$1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today - Insmed ( NASDAQ:INSM )
Insmed INSM has outperformed the market over the past 10 years by 3.48% on an annualized basis producing an average annual return of 14.26%. Currently, Insmed has a market capitalization of $14.37 billion.
